Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations [0.03%]
非酒精性脂肪肝病的临床意义、不良结局和治疗考虑在妊娠中的作用
Diego F Wyszynski
Diego F Wyszynski
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive condition characterized by excess hepatic fat accumulation in the absence of significant hepatocellular injury. Its mo...
Screening for Malnutrition, Sarcopenia, and Physical Frailty Beyond One Year after Liver Transplantation [0.03%]
肝移植术后一年以上患者的营养不良、肌少症和身体衰弱筛查
Amal Trigui,Crystèle Hogue,Mélanie Tremblay et al.
Amal Trigui et al.
Background/aims: Malnutrition, sarcopenia, and frailty negatively impact quality of life and increase mortality following liver transplantation (LT). However, long-term follow-up data remain limited. This study aimed prim...
Assessment of Usability and Acceptability of Blood-based Hepatitis C Virus Self-testing Among Residents of Urban Slums in Northern India: A Cross-sectional Study [0.03%]
印度北部城市贫民窟居民自我检测血液中的丙型肝炎病毒的使用性和可接受性评估：横断面研究
Ajeet S Bhadoria,Amrita Mehndiratta,Kathirvel Soundappan et al.
Ajeet S Bhadoria et al.
Background/aims: Globally, only 36% of people with hepatitis C are aware of their infection, and just 20% of those diagnosed receive treatment, highlighting a significant diagnosis and treatment gap. The World Health Orga...
When Clips Travel [0.03%]
当剪辑游走时
Nenavath R Naik,Rajkumar Wadhwa,Aathira Ravindranath et al.
Nenavath R Naik et al.
Phenotype-specific Inflammatory Profiles in Steatotic Liver Disease: Implications for Identifying Fibrosis [0.03%]
脂肪变性肝病的表型特异性炎症谱特征及其在识别纤维化方面的意义
Akshay B Verma,Arihant Seth,Piyush Dadhich et al.
Akshay B Verma et al.
Background and aims: Liver fibrosis is a key prognostic factor in steatotic liver diseases (SLD), including metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic and alcohol-associated liver disease ...
"Facts are Stubborn Things, but Statistics are Pliable" - Concerns Regarding Meta-Analysis of Granulocyte Colony-Stimulating Factor Therapy in Severe Alcohol-Associated Hepatitis [0.03%]
“事实是顽固的，但统计是易变的”——关于粒细胞集落刺激因子治疗重度酒精性肝炎的meta分析存在的问题
Cyriac A Philips,Tharun T Oommen,Rizwan Ahamed et al.
Cyriac A Philips et al.
Validation of Quantitative Magnetic Resonance Cholangiopancreatography Metrics in Prediction of Transplant-free Survival in Primary Sclerosing Cholangitis [0.03%]
定量磁共振胆胰管造影指标预测原发性硬化性胆管炎移植后生存价值的验证研究
Tim E Middelburg,Bregje Mol,Carlos Ferreira et al.
Tim E Middelburg et al.
Background and aims: Qualitative magnetic resonance cholangiopancreatography (MRCP) scoring models in primary sclerosing cholangitis (PSC) are hampered by interobserver variability and evidence for quantitative MRCP has s...
Endovascular Interventions for the Secondary Prophylaxis of Gastric Varices Prevent Rebleeding but May Not Improve Overall Survival: A Real-world Cohort From Two Centers [0.03%]
二次预防胃静脉曲张出血的血管内介入治疗可以防止再出血但可能无法改善整体生存率：来自两家中心的真实世界队列研究
Sagnik Biswas,Santhosh E Kumar,Sanchita Gupta et al.
Sagnik Biswas et al.
Background: There is limited literature on the long-term outcomes of patients with cirrhosis following an index gastric variceal (GV) hemorrhage. Methods:...
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes [0.03%]
代谢紊乱相关脂肪性肝病(MASLD)的管理：现状与展望
Luigi E Adinolfi,Aldo Marrone,Antonio Izzi et al.
Luigi E Adinolfi et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a newly defined clinical condition characterized by hepatic steatosis in the presence of one or more cardiometabolic risk factors (CMRFs), such as obesity, type 2 diabetes,...
Hepatitis B Reactivation in Children During Chemotherapy for Hematologic Malignancies: Experience of 24 Cases Including Long-term Follow-up [0.03%]
儿童化疗期间乙型肝炎再激活的临床特征及影响因素——24例病例报告及长期随访数据分析
Harshad Devarbhavi,Mallikarjun Patil
Harshad Devarbhavi
Background/aims: Hepatitis B virus reactivation (HBVr) or acute hepatitis B virus (HBV) infection is a known complication in adults receiving chemotherapy, often leading to significant hepatic morbidity and even liver fai...